"Mesothelioma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A tumor derived from mesothelial tissue (peritoneum, pleura, pericardium). It appears as broad sheets of cells, with some regions containing spindle-shaped, sarcoma-like cells and other regions showing adenomatous patterns. Pleural mesotheliomas have been linked to exposure to asbestos. (Dorland, 27th ed)
Descriptor ID |
D008654
|
MeSH Number(s) |
C04.557.470.035.510 C04.557.470.660.510
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Mesothelioma".
Below are MeSH descriptors whose meaning is more specific than "Mesothelioma".
This graph shows the total number of publications written about "Mesothelioma" by people in this website by year, and whether "Mesothelioma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 2 | 0 | 2 |
1996 | 1 | 0 | 1 |
1997 | 1 | 2 | 3 |
1998 | 2 | 0 | 2 |
1999 | 3 | 0 | 3 |
2000 | 5 | 0 | 5 |
2001 | 6 | 0 | 6 |
2002 | 1 | 1 | 2 |
2003 | 9 | 2 | 11 |
2004 | 4 | 1 | 5 |
2005 | 15 | 1 | 16 |
2006 | 7 | 0 | 7 |
2007 | 8 | 1 | 9 |
2008 | 8 | 1 | 9 |
2009 | 10 | 1 | 11 |
2010 | 7 | 0 | 7 |
2011 | 9 | 0 | 9 |
2012 | 10 | 0 | 10 |
2013 | 6 | 2 | 8 |
2014 | 9 | 1 | 10 |
2015 | 9 | 1 | 10 |
2016 | 11 | 1 | 12 |
2017 | 11 | 3 | 14 |
2018 | 14 | 1 | 15 |
2019 | 16 | 1 | 17 |
2020 | 10 | 1 | 11 |
2021 | 3 | 1 | 4 |
2022 | 16 | 0 | 16 |
2023 | 6 | 0 | 6 |
2024 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mesothelioma" by people in Profiles.
-
Oncolytic adenoviruses and immunopeptidomics: a?convenient marriage. Mol Oncol. 2024 Apr; 18(4):781-784.
-
Mesothelioma: Pleural, Version 1.2024. J Natl Compr Canc Netw. 2024 03; 22(2):72-81.
-
Response letter to "Stereotactic body radiation therapy for pleural mesothelioma: Which goal, which patients". Radiother Oncol. 2024 Apr; 193:110138.
-
Clinical outcomes of stereotactic body radiation therapy for malignant pleural mesothelioma. Radiother Oncol. 2024 Feb; 191:110057.
-
Tumor-Targeted Nonablative Radiation Promotes Solid Tumor CAR T-cell Therapy Efficacy. Cancer Immunol Res. 2023 10 04; 11(10):1314-1331.
-
Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2023 09; 21(9):961-979.
-
The International Association for the Study of Lung Cancer Pleural Mesothelioma Staging Project: Updated Modeling of Prognostic Factors in Pleural Mesothelioma. J Thorac Oncol. 2023 12; 18(12):1689-1702.
-
Mesotheliomas and Benign Mesothelial Tumors: Update on Pathologic and Imaging Findings. Radiographics. 2023 03; 43(3):e220128.
-
A Phase II Window of Opportunity Study of Neoadjuvant PD-L1 versus PD-L1 plus CTLA-4 Blockade for Patients with Malignant Pleural Mesothelioma. Clin Cancer Res. 2023 02 01; 29(3):548-559.
-
Sensitivity and complications of thoracentesis and thoracoscopy: a meta-analysis. Eur Respir Rev. 2022 Dec 31; 31(166).